Monitor the Amsterdam acquisition timeline and conditions precedent for closing, including shareholder and regulatory approvals under the UK Takeover Code. The bridge facilities carry step-up pricing and duration fees that increase the cost of capital if the acquisition is delayed beyond 90 days post-closing. Watch for any equity issuance or permanent financing takeout that would reduce the bridge exposure.
Price Chart
Executive Summary
H.B. Fuller Company entered into secured ($1.387B term + $700M revolver) and unsecured ($917M term) bridge credit agreements with Goldman Sachs Bank USA as administrative agent, dated June 25, 2026, to finance the acquisition of Advanced Medical Solutions Group PLC (Amsterdam). The facilities are 364-day bridge loans with step-up pricing and duration fees, secured by assets of the borrower and certain domestic subsidiaries. The acquisition is structured as a UK scheme of arrangement or offer, with conditions including regulatory approvals and minimum acceptance thresholds.
Key Financial Metrics
Key Facts
- Secured Bridge Credit Agreement: $1,386,713,188 term loan + $700,000,000 revolving credit facility
- Unsecured Bridge Credit Agreement: $917,000,000 term loan
- Both agreements dated June 25, 2026, with 364-day maturity from closing
- Goldman Sachs Bank USA is administrative agent, sole lead arranger, and bookrunner for both facilities
- Proceeds to finance acquisition of Advanced Medical Solutions Group PLC (Amsterdam)
- Interest rates: secured facility at SOFR + 1.75% (term/benchmark) stepping up 0.25% every 90 days; unsecured facility at SOFR + 2.50% stepping up 0.25% every 90 days
- Duration fees on secured term loans: 0.50% at 90 days, 0.75% at 180 days, 1.00% at 270 days post-closing
- Financial covenants: minimum interest coverage ratio of 2.00x and maximum secured leverage ratio of 4.50x (stepping to 5.00x for material acquisitions)
Financial Impact
Total committed bridge financing of approximately $3.0 billion ($1.387B secured term + $0.7B secured revolver + $0.917B unsecured term) to fund the Amsterdam acquisition and refinance existing debt. No purchase price or premium disclosed.
Risk Factors
- Acquisition may not close if conditions (minimum 75% acceptance for offer, scheme effective date) are not met
- Step-up pricing and duration fees increase financing costs if bridge is outstanding beyond 90 days
- Leverage will increase materially post-acquisition, with secured leverage covenant at 4.50x (5.00x with material acquisition election)
- Cross-border UK regulatory and Takeover Code compliance risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-021844 |
| Exhibit: ex_981231.htm | 0001437749-26-021844 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $50.89 | awaiting T+5 | — | $49.13 (−3.46%) |
Oct 19, 2026 7d ago | 8-K | $51.06 $49.13 | ▼ −3.78% | ▼ −3.63% | $49.13 (−3.78%) |
Oct 9, 2026 17d ago | 8-K | $49.56 $51.32 | ▲ +3.55% | ▲ +5.52% | $49.13 (−0.87%) |
Oct 6, 2026 20d ago | 8-K | $50.63 $50.44 | ▼ −0.38% | ▼ −0.24% | $49.13 (−2.96%) |
Oct 1, 2026 25d ago | Insider Cluster | $50.23 $50.44 | ▲ +0.42% | ▼ −0.88% | $49.13 (−2.19%) |
Oct 1, 2026 25d ago | Insider Cluster | $50.23 $50.44 | ▲ +0.42% | ▼ −0.88% | $49.13 (−2.19%) |
Sep 30, 2026 26d ago | Insider Cluster | $49.47 $49.91 | ▲ +0.89% | ▼ −1.02% | $49.13 (−0.69%) |
Sep 28, 2026 28d ago | 8-K | $49.37 $50.44 | ▲ +2.17% | ▲ +0.96% | $49.13 (−0.49%) |
Sep 24, 2026 4w ago | 8-K | $50.00 $50.23 | ▲ +0.46% | ▲ +0.88% | $49.13 (−1.74%) |
Jul 20, 2026 14w ago | 8-K | $55.43 $55.70 | ▲ +0.49% | ▲ +0.91% | $49.13 (−11.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers